Skip to content

Researchers developed a novel way to image inflammation in multiple sclerosis, a disease that is notoriously difficult to diagnose early.

Researchers developed a novel way to image inflammation in multiple sclerosis, a disease that is notoriously difficult to diagnose early.

Published on

Speakers at Stanford's Big Data in Precision Health conference discuss how their work with big data impacts and informs sleep research.

Speakers at Stanford's Big Data in Precision Health conference discuss how their work with big data impacts and informs sleep research.

Type 1 diabetes starts out as a sneak attack by bad-actor antibodies. But scientists at Stanford and UCSF have developed an early-warning system.

Type 1 diabetes starts out as a sneak attack by bad-actor antibodies. But scientists at Stanford and UCSF have developed an early-warning system.

Published on

Stanford scientists have dug up a defect at the heart of rheumatoid arthritis: a faulty "anchor" that should be tethering a key molecule to the spot inside immune cells where it has to be in order to do its job.  It seems this defect can be reversed with a not yet commercially available small-molecule drug.

Stanford scientists have dug up a defect at the heart of rheumatoid arthritis: a faulty "anchor" that should be tethering a key molecule to the spot inside immune cells where it has to be in order to do its job.  It seems this defect can be reversed with a not yet commercially available small-molecule drug.

Published on

In a video, Stanford Children's Health's Healthier, Happier Lives Blog introduces a patient with celiac disease and discusses the symptoms, diagnosis and treatment of the autoimmune disorder.

In a video, Stanford Children's Health's Healthier, Happier Lives Blog introduces a patient with celiac disease and discusses the symptoms, diagnosis and treatment of the autoimmune disorder.

Rheumatoid arthritis and coronary artery disease share a common culprit: an important type of immune cell, called a macrophage, that has gone haywire. Stanford investigators have zeroed in on a molecular defect in macrophages' metabolic process that drives both disorders.

Rheumatoid arthritis and coronary artery disease share a common culprit: an important type of immune cell, called a macrophage, that has gone haywire. Stanford investigators have zeroed in on a molecular defect in macrophages' metabolic process that drives both disorders.